Cancers, Vol. 11, Pages 114: Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines

Cancers, Vol. 11, Pages 114: Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines

Cancers doi: 10.3390/cancers11010114

Authors: Barbara Rath Lukas Klameth Adelina Plangger Maximilian Hochmair Ernst Ulsperger Ihor Huk Robert Zeillinger Gerhard Hamilton

Small cell lung cancer (SCLC) is an aggressive type of lung cancer which disseminates vigorously and has a dismal prognosis. Metastasis of SCLC is linked to an extremely high number of circulating tumor cells (CTCs), which form chemoresistant spheroids, termed tumorospheres. Intravasation and extravasation during tumor spread requires the activity of a number of proteases to disintegrate the stroma and vascular tissue. Generation of several permanent SCLC CTC lines allowed us to screen for the expression of 35 proteases using Western blot arrays. Cell culture supernatants of two CTC lines, namely BHGc7 and 10, were analyzed for secreted proteases, including matrix metalloproteinases (MMPs), ADAM/TS, cathepsins, kallikreins, and others, and compared to proteases expressed by SCLC cell lines (GLC14, GLC16, NCI-H526 and SCLC26A). In contrast to NCI-H526 and SCLC26A, MMP-9 was highly expressed in the two CTC lines and in GLC16 derived of a relapse. Furthermore, cathepsins (S, V, X/Z/P, A and D) were highly expressed in the CTC lines, whereas ADAM/TS and kallikreins were not detectable. In conclusion, SCLC CTCs express MMP-9 and a range of cathepsins for proteolysis and, aside from tissue degradation, these enzymes are involved in cell signaling, survival, and the chemoresistance of tumor cells.

http://bit.ly/2U4OlR7